Autonomic Nervous System Disorders Syncope, Palpitation. Body as a Whole-general disorders: Asthenia, Fever, Hernia. Cardiovascular disorders Cardiac failure. Central and peripheral nervous system disorders Cramps legs, Hypoaesthesia, Neuralgia, Paraesthesia, Vertigo. Gastrointestinal system disorders Constipation, Vomiting. Heart rate and rhythm disorders Fibrillation atrial. Liver and biliary system disorders Hepatic enzymes increased. Metabolic and nutritional disorders Gout, hyperuricemia, non-protein nitrogen (NPN) increased. Musculo-skeletal system disorders Arthritis, Arthrosis. Platelet, bleeding & clotting disorders GI hemorrhage, hematoma, platelets decreased. Psychiatric disorders: Anxiety, Insomnia. Red blood cell disorders Anemia. Respiratory system disorders Pneumonia, Sinusitis. Skin and appendage disorders Eczema, Skin ulceration. Urinary system disorders Cystitis. Vision disorders Cataract, Conjunctivitis. Other potentially serious adverse events which may be of clinical interest but were rarely reported (<1%) in patients who received PLAVIX in the CAPRIE or CURE controlled clinical trials are listed below regardless of relationship to PLAVIX. In general, the incidence of these events was similar to that in patients receiving aspirin (in CAPRIE) or placebo + aspirin (in CURE). Body as a whole Allergic reaction, necrosis ischemic. Cardiovascular disorders Edema generalized. Gastrointestinal system disorders Gastric ulcer perforated, gastritis hemorrhagic, upper GI ulcer hemorrhagic. Liver and Biliary system disorders Bilirubinemia, hepatitis infectious, liver fatty. Platelet, bleeding and clotting disorders hemarthrosis, hematuria, hemoptysis, hemorrhage intracranial, hemorrhage retroperitoneal, hemorrhage of operative wound, ocular hemorrhage, pulmonary hemorrhage, purpura allergic, thrombocytopenia. | ||||
Email this article
Printer friendly
Bookmark this pageadvertisement
